Business Money News U.S.

MedMen Enterprises: From Cannabis Industry Hero to $0

Prior to completing a go-public transaction, we were cautious with MedMen Enterprises Inc. (MMEN.CN) (MMNNF) and considered it to be an opportunity to avoid.

Many of our readers did not agree with our view of the business and argued our rationale due to the brand that the management team has been able to build. We stuck to our beliefs with MedMen and we are glad that we did.

The last two years have been a disaster for MedMen, which owns several dispensaries in high-profile US cannabis markets. The management team that was involved with the IPO clearly was operating in the best interests of themselves and were taking huge salaries while the business remained in the startup phase of growth

On Friday, our view on MedMen was justified when Canaccord Genuity (CF.TO) assigned the US cannabis retailer a $0 price target. The Canadian broker-dealer reiterated its sell rating on MedMen and lowered the previously issued $0.25 price target.

To Read The Rest Of This Article By Michael Berger on Technical420

Published: October 20, 2020

SHARE
RELATED POSTS
Paragon Partners With Civic Technologies to Deliver Transparency, Digital IDs to Cannabis Industry
Medmen Enterprises Inc Spirals on New Numbers
Screening of Cannabis License Applications Is Underway in WeHo

Leave Your Reply

*